|

Vonsetamig Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Also known as: REGN5459

Pipeline

Phase 1: 1

Top Sponsors

  • Regeneron Pharmaceuticals1

Indications

  • Lupus Nephritis (LN)1
  • Lupus1

San Francisco, California1 trial

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

University of California San Francisco - Zuckerberg San Francisco General

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.